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In this work we have theoretically investigated how the action potential generation and its as-
sociated intrinsic properties are affected in presence of ion channel blockers by adapting Gillepie’s
stochastic simulation technique on a very basic neuron of Hodgkin-Huxley type. With a simple
extension of the Hodgkin-Huxley Markov model we have mainly investigated three types of drug
blocking mechanism such as (i) only sodium channel blocking, (ii) only potassium channel blocking
and (iii) dual type blocking and showed that the major experimental and physiological observations
such as ionic currents, spiking frequency trends, change in action potential shape and duration,
altered gating dynamics etc due to the presence of ion channel blockers can be well reproduced.
Our results show that the nature of action potential termination process in presence of sodium and
potassium channel blockers are distinct and physiologically very different from each other. We have
found that although the sodium and potassium ionic currents have interdependent relationship over
a course of an action potential but sodium and potassium channel blockers have distinct signatures
on ionic currents. In presence of only sodium channel blockers the frequency of action potential
generation falls off exponentially with increasing drug affinity, whereas in contrast, for only potas-
sium channel blockers initially an enhanced spiking activity of action potential is found followed
by a gradual decrease of the spiking frequency as the drug affinity increases. In case of dual type
blockers with equal sodium and potassium channel binding affinity, the spiking frequency passes
through maxima and minima due to the competition between channel number fluctuation and over-
all sodium and potassium conductances. We have found that sodium channel blockers shorten the
duration of action potential while the potassium channel blockers delay it which are of great phys-
iological and pharmacological importance. We have also shown how the ion channel blockers alter
the gating dynamics and such altered gating itself modulates the ion channel blocking which opens
the possibility of finding fundamental informations regarding probabilistic and dynamical features.
Some experimental results of ion channel blocking in diverse systems have been validated through
our site selected binding scheme. Many other types of blocking mechanisms such as closed state
blocking, inactive state blocking etc can also be explored using our method with desired level of
structural and functional details.
Keywords: Ion Channels; Sodium Channel Blockers; Potassium Channel Blockers; Action po-
tential, Local Anesthetics, Gillespie simulation.
I. INTRODUCTION
Ion channels are typically very complex transmem-
brane proteins[1] exhibiting a high degree of both struc-
tural and functional diversity[2]. They have very distinct
electrical potential dependent gating mechanism where
the protein structures can adopt several conformational
states such as closed, open and inactive states in which
states they can either transport ions across the mem-
brane creating pores or restrict the ion permeability by
closing the pore when required[3]. The ion channels are
∗Electronic address: +pckp@iacs.res.in,*gautam@bose.res.in
responsible for generating action potentials which are the
basic requirement of cell to cell communication and sig-
nal propagation in nervous system[2]. Among the var-
ious cation, anion and neutral ion channels in general
sodium and potassium channels are mainly responsible
for action potential generation and its termination in
most of the neurons. There exists certain compounds
or molecules, typically called as ion channel blockers
which selectively bind to specific protein conformations
of the ion channels and regulate their gating mechanism
by blocking the passage of ions across the membrane.
The high degree of specificity of these channel blockers
on certain channels make them a valuable tool to treat
numerous neural disorders[4–6]. Channel blockers of dif-
ferent types such as cationic blockers, anionic blockers,
2amino acids, and other chemicals regulate the functional
properties of the channel or prevent them to respond nor-
mally. The naturally occurring sodium channel selective
blocker TTX[7] was known since 1964, followed by Sax-
itoxin (STX), Neosaxitoxin (NSTX). Local anesthetics
such as Lidocain, Phenytoin, Amiloride, Bupivacaine and
Tetracaine etc are clinically used[8, 9] for sodium channel
blocking. On the other hand potassium channel blockers,
such as 4-aminopyridine and 3, 4-diaminopyridine etc are
used as local anaesthetics[10] and Tetraethylammonium
(TEA) is used only for experimental purpose[6, 11]. A
sodium blocker that blocks the open pore of the channel
are called open state blocker[8, 12, 13]. Also there exists
closed state blocker, inactive state stabilizing blockers
etc[8, 12, 13]. Potassium channel blockers either bind
with the selectivity filter or at the central cavity(open
state) of the channel[14]. From the discovery of TTX
toxicity[7] the present knowledge of ion channel block-
ers have been a very vast, complicated and rigorous
journey which was mostly developed for pharmacologi-
cal interests[4–6, 9, 11].
Recently Markov modelling and computer simula-
tions prove to be promising techniques which provide
new insights into the fundamental principle and mech-
anism about how these drugs alter the normal biologi-
cal process[5, 15]. Single channel Markov models with
discrete protein conformational states can simulate state
specific channel properties and their alterations by mu-
tations, disease or drug binding[15]. As Markov mod-
els can be developed both at the level of single chan-
nel activity and at the macroscopic state, they pro-
vide an implicit relationship between the single channel
recording and the macroscopic current[16]. Now the fa-
mous neuronal action potential model of Hodgkin and
Huxley[17] is based on an assumption that the ion per-
meation process can be approximated as both continu-
ous and deterministic[17] as it considers infinite number
of ion channels inside a neuron. However, the perme-
ation process existing within active membrane is now
known to be neither continuous nor deterministic. Ac-
tive membrane consists of finite number of ion channels
which undergo random fluctuations between open and
closed states[2] which scale inversely proportional to the
number of channels present in a particular patch of a
neuron. Recent works also reveal that fluctuation in the
states of these channels are physiologically important in
small neuronal structures[18–21]. When the number of
ion channels inside a neuron cell membrane is finite or
small, the effect of internal noise become more and more
important[18, 21–23]. Channel number fluctuations can
itself cause spontaneous spiking activity[23] without any
stimulus and thereby the stochastic version of Hodgkin-
Huxley model is proposed[18, 20, 23]. Therefore, the ef-
fect of channel noise can not be ignored also in the study
of drug binding. Although innumerable number of exper-
iments have been performed to study the channel block-
ing phenomena, the theoretical investigation and com-
prehensive understanding of the state specific blocking
still requires detailed investigation from which the corre-
sponding physiological consequences of drug blocking can
be deduced that too from the level of action potential de-
scription itself. From the vast number of studies already
made it is very difficult to comprehend the mechanistic
link between the site specific blocking and the biophysical
consequences of that. So a microscopic reverse analysis
is necessary from theoretical perspective to validate the
known observations.
Inspired by the work done by Schmid, Goychuk and
Ha¨nggi[24] on the effect of ion channel blockers using
Langevin type of stochastic description, we present here
a simple yet detailed and realistic approach for chan-
nel blocking kinetics using the standard Markovian squid
axon model of Hodgkin-Huxley[17] which represents a
basic neuron cell type. We have incorporated new drug
blocked states in the original Hodgkin-Huxley model to
theoretically extend it to a drug binding model. We then
have suitably adapted Gillespie[25] stochastic simulation
algorithm to study the effect of ion channel blockers on
action potential, ionic current, spiking frequency, action
potential duration and gating dynamics in moderately
stochastic limit of channel noise. We have proposed
three types of drug blocking mechanisms, e.g, sodium
channel only blocking, potassium channel only blocking
and a dual type blocking scheme with comparative bind-
ing affinity to these two channels. We have shown here
through a few experimental evidences[26–38] that our ap-
proach successfully correlates to the known physiological
effects of ion channel blocking.
The Layout of the paper is as follows. In Section (II)
we have discussed the kinetic scheme of drug blocking and
the suitable modification of the simulation algorithm for
the present purpose. Effect of channel noise on the action
potential has been discussed also under this section. In
Section (III) the sodium and potassium channel blocking
effects on the trains of action potential have been dis-
cussed with fundamental biophysical details. In Section
3(IV) comparative study on the effect of different types of
blockers on ionic current, spiking frequency, action po-
tential duration and gating dynamics has been discussed
under various subsections. In Section (V) we have dis-
cussed how our results are in good agreement with the
experimental and theoretical works done earlier. Finally
the paper is concluded in Section (VI).
II. PROPOSED KINETIC SCHEME AND
STOCHASTIC SIMULATION OF ACTION
POTENTIAL IN PRESENCE OF CHANNEL
BLOCKERS
The stochasticity in the Hodgkin-Huxley model
is implemented in two ways such as theoretical
approximation[39] method where it approximates the dy-
namics of the internal gating variables are governed by
Langevin[39] type of description of stochasticity, where
the Gaussian white noise terms are added to the internal
gating dynamical variables, described in the later part of
this paper. The other one is the computational stochas-
tic simulation based on kinetic Monte-Carlo simulation
of Hodgkin-Huxley Markov model[18–20, 25, 40–44]. In
this paper we have used the second one.
A. Markov Model of Hodgkin-Huxley Action
Potential Simulation
Here we briefly describe the Hodgkin-Huxley Markov
model and its kinetic scheme. The Hodgkin and
Huxley(1952)[17] gating mechanism consists of four ac-
tivating n gates for potassium channel and its Markov
model consists of five states, such as, n0(resting state,
when all four gates are closed), n1(only one gate is open),
n2, n3 and n4(open state or the single ion conducting
state, when all four gates are open). The model of potas-
sium channel thus have 8 transition rates designated by
αns and βns between these 5 states. On the other hand,
the sodium channel has three activating m gates with
four distinct states and one inactivating h gate with
two distinct states. Thus the kinetic scheme based on
Markov process has 8 states, such as,m0h0(resting state),
m1h0,m2h0,m3h0,m0h1,m1h1,m2h1,m3h1(open state
or ion conducting state), with a total of 20 transition
rates designated by αm,hs and βm,hs. Thus as a whole
there are 28 transitions between 13 states to be consid-
ered for simulating action potential[43]. Each ion channel
randomly fluctuates between these discrete states.
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FIG. 1: Markov model of Potassium and Sodium
ion channel: The potassium channel in figure (a) is a
five state model where we have added an extra
‘drug-bound’ state, DP . Similarly in figure (b) sodium
channel is an eight state model where we have added a
‘drug-bound’ state, DS .
The expressions of the voltage dependent rates[23]
are given as follows αm(V ) = (0.1(V + 40))(1 −
exp[−(V + 40)/10])−1, βm(V ) = 4 exp[−(V +
65)/18], αh(V ) = 0.07 exp[−V + 65)/20], βh(V ) =
1 + exp[−(V = 35)/10]
−1
, αn(V ) = (0.01(V + 55))(1 −
exp[−(V +55)/10])−1, βn(V ) = 0.125 exp[−(V +65)/80].
The Hodgkin-Huxley[17] action potential or transmem-
brane voltage, V is given by the equation,
Cm
d
dt
V (t) +GK(t)(V (t)− EK) +GNa(t)(V (t)− ENa) +GL(V (t)− EL) = Iext(t). (1)
Here V is in mV unit and the rates are in ms−1. Param-
eters and their descriptions are given in TABLE I [23].
4Cm Membrane capacitance 1 µF/cm
2
EK K
+ reversal potential -77.0 mV
ρK K
+ channel density 18 channels/ µm2
gmaxK Maximal K
+ channel conductance(all K+ channels are open) 36.0 mS/cm2
γK Single K
+ channel conductance 20 pS
ENa Na
+ reversal potential 50.0 mV
ρNa Na
+ channle density 60 channels/µm2
gmaxNa Maximal Na
+ channel conductance(all Na+ channels are open) 120.0 mS/cm2
γNa Single Na
+ channel conductance 20 pS
EL Leak reversal potential -54.4 mV
gL Leak conductance 0.3 mS/cm
2
TABLE I: Parameters of Hodgkin-Huxley equation[23].
For a discrete stochastic channel populations the potas-
sium and sodium membrane conductances across are ex-
pressed by the following equations (2),
GK(V, t) = g
max
K [Nn4/NK ] , (2a)
GNa(V, t) = g
max
Na [Nm3h1/NNa] , (2b)
where Nn4 and Nm3h1 are the number of potassium and
sodium channels in open state, respectively and NK and
NNa are the total number of potassium and sodium chan-
nels present in the membrane patch considered, respec-
tively. Solving the stochastic simulation one obtains the
population of individual states from which the open state
populations for sodium and potassium channel are put
into conductance equation (2) and then solving equation
(1) one obtains the action potential.
B. Proposed Scheme of Channel Blocking
Now, in this work we have studied the effect of ion
channel blockers on action potential. Ion channel block-
ers can bind to several conformational states of ion chan-
nels such as closed state, inactivated state and open-state
of ion channels[2]. However, here we have only considered
the case of those blockers which preferentially bind to the
open states of the channels. As these blockers block the
open-pore of the channel and hinder ion permeation, we
can think of a state, say,“drug bound” state which is ac-
cessible only if the channels enter the open state. Thus
the drug bound state is coupled to the open state of the
sodium or potassium channel. The drug bound state ba-
sically represents the state of channels which are blocked
by the blockers. To implement this on potassium chan-
nel we designate this drug bound state as DP and for
sodium channel it is DS as seen from figure (1). The
forward transition rate for sodium or potassium blocking
are given by ‘kxon’, where x=s for sodium blockers and
x=p for potassium blockers. The affinity of drug bind-
ing is usually defined as kxon= kxb*[D], where kxb is the
binding constant of the drug and [D] is the concentra-
tion of the drug[12]. Thus any change of the value of
‘kxon’ means the change of concentration of the block-
ers or drugs of a particular type having specific binding
constant.
Now the backward transition for reopening is a very
slow process compared to the forward. Channel block-
ers or local anesthetics take around 1-4 hours(duration
of action) before they are completely removed1 from the
channel proteins[45]. In general, clinically used channel
blockers or local anesthetics can be divided into three
categories: short acting (e.g., 2-chloroprocaine, 45-90
minutes), intermediate duration (e.g., lidocaine, mepi-
vacaine, 90-180 minutes), and long acting (e.g., bupi-
vacaine, levobupivacaine, ropivacaine, 4-18 hours)[45].
Thus it is seen that elimination of the drug from the
site or the recovery of the channel is a very slow pro-
cess compared to that of drug binding where the onset
of local anaesthetic actions take place within few min-
utes(as we shall also see that the simulation runs with
the transition rates mentioned earlier take few seconds
only to completely terminate the action potential gen-
eration for a patch area we have considered in this pa-
per). Thus the backward flux can therefore reasonably
be considered as a very small valued constant during the
1 Amide blockers(lidocaine, bupivacaine, mepivacaine etc) are bio-
transformed in the liver, ester blockers(cocaine, benzocaine, pro-
caine etc ) are hydrolyzed in the bloodstream by plasma esterases
or the hydrolysis of the side chains of the blockers make them
inactive and then they are eliminated via blood circulation[45].
5course of drug binding action. We designate the back-
ward flux as FxB=0.001, a constant throughout
2. Now,
we have gradually increased the drug binding affinity,
kxon from 0.0001 to 1.0 or more, keeping FxB=0.001,
constant. When we consider only sodium blockers we
do not consider the potassium blocking state, DP and
vice verse except for dual type of blocking as we shall
discuss later. Thus with the attached single drug-bound
state Hodgkin-Huxley model now have 14 states and 30
transition rates.
C. Stochastic Ion Channel Simulation Using
Gillespie Algorithm
The computer based stochastic simulation algorithm
using Markovian model can be classified into two al-
gorithms, such as, i) Channel-State-Tracking(CST) al-
gorithm and ii) Channel-Number-Tracking(CNT) algo-
rithm. The CST algorithm tracks the specific states of
each channel and superimposes individual channel cur-
rents corresponding to the states. This algorithm al-
though simple but it is computationally very costly and
intensive[19–21]. However an easy alternate is CST algo-
rithm using Gillespie method[25, 40, 42, 43] which keeps
track of the number of channels in each state with the
assumption that multi-channel systems are independent
and memoryless. This Channel Number Tracking(CNT)
algorithm provides much greater efficiency in cases where
many channels are simulated as the algorithm calculates
an effective transition rate associated with the multi-
channel system by allowing only one transition among
all states in a random time interval. Thus in this paper
we have utilized Gillespie’s CST simulation algorithm to
study the effect of ion channel blockers. The simulation
method is very well known in the literature[25, 40, 42, 43].
The steps that we considered to develop the stochastic
2 There is roughly 18,000 channels in total are present in 200 µm2
patch area(area that we have chosen in this work). If we even
consider the blocking action prolongs for 1 hour, then the approx-
imate flux becomes FxB ≈
1
1×3600×103
× 18000 ≈ 0.005. Now
in fact not exactly 18000 blocked channels will be there. Blood
circulation hinders the channel blockers to penetrate the lipid bi-
layers by washing them out and a certain fraction of the blockers
can enter to block channels, thus have lesser chance to block all
the channels, also density of the patch is not homogeneous ev-
erywhere that some patches can have lesser number of channels.
Besides some drug actions last more than 4 hours. Consider-
ing these facts together we have taken a lower value which is
0.001(easy to compare), which hardly impacts the nature of the
results as we have verified.
algorithm for the site selective binding of sodium and
potassium blockers for a particular patch size of a neu-
ron have been elaborately discussed in Appendix (A1).
D. Effect of Channel Number Fluctuation
Next we have studied the action potential and con-
ductance of sodium and potassium channels without the
presence of external stimulus or external current, Iext =
0.0µA/cm2. We start from very high stochastic limit of
channel noise with patch size as low as A = 1.0 µm2
and extend it to the deterministic limit such as A = 200
µm2. Here we do not consider the presence of any drug,
hence kxon = FxB = 0.0. Thus here we consider 13 states
and 28 reactions: the original Hodgkin-Huxley model. In
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FIG. 2: Effect of channel number fluctuation on
action potential: Action potentials of various patch
size are plotted here. From (a) to (d) the action
potentials are shown for A= 1.0, 10.0, 100.0, 200.0 µm2
at Iext = 0.0 µA/cm
2. It shows how the effect of
channel noise and consequent spontaneous action
potential generation falls off as the deterministic limit is
approached.
figure (2) we have shown how the action potential vary
from patch size, A=1.0 to 200 µm2. As seen from figure
2(a) that at very low patch size channel noise plays very
important role. These channel number fluctuations can
alone originate spontaneous spiking activity[23] without
even the presence of external current. As soon as the
patch size is increased the spontaneous spiking rate de-
creases. As we can see at moderately high patch size,
6for example, A = 200µm2, the spiking phenomenon van-
ishes away and system behaves similarly as it does in
deterministic limit at Iext = 0.0µA/cm
2.
As a side note we would like to mention here that the
Gillespie method that we have used to simulate action
potential, although is a very popular method and often
claimed to be an exact simulation technique in litera-
ture, however, contrary to that popular belief it can not
be claimed as an exact method especially while consider-
ing very low patch sizes. It is basically an approximate
method which works fine for higher patch sizes. A brief
discussion about its applicability has been discussed in
Appendix (A2). Exact simulation for figure 2 (a) and
(b) is beyond the scope here. These two plots are not ex-
act but here their sole purpose is to convey the message
that at low patch sizes the channel fluctuations do play
very important role.
III. SODIUM AND POTASSIUM CHANNEL
BLOCKERS
Now we come to the main focus of this work, i.e. study-
ing stochastic drug binding kinetics in ion channels. To
see the effect on action potentials we have gradually in-
creased the external stimulus from zero to higher values
and seen that at Iext = 6.9 µA/cm
2 they show consid-
erable amount of spiking activity. The values of ionic
current lesser than 6.9 µA/cm2 show very irregular spik-
ing pattern with higher intervals which requires very long
time simulations and become very clumsy to be presented
in plots. At this selected value of ionic current they show
considerable amount of spiking activity with lesser in-
tervals which can be plotted very nicely and helps us
to interpret the effect of drugs on action potential spik-
ing trend. However the results in general discussed here
show exactly similar behavior for all other choices of Iext
other than zero. We have kept the patch size, A=200
µm2 for which the effect of channel number fluctuation
is moderately close to the deterministic limit but not ex-
actly the deterministic limit, because with the value of
Iext = 6.9 µA/cm
2, a considerably higher patch size is re-
quired to match deterministic result. On the other hand
at very low patch size the channel noise makes it almost
impossible to study the binding effects. At this value
of patch size, A=200 µm2, we are dealing with almost
12000 sodium channels and 3600 potassium channels.
A. Only Sodium Channels Are Blocked
As mentioned earlier, here we have considered only the
open state sodium channel blockers in this study. Here we
do not add any potassium blockers together. Thus here
only DS state is present not DP . In figure (3) we have
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FIG. 3: Effect of sodium channel only blockers:
Action potentials in presence of sodium channel only
blockers with increasing affinities are plotted here. In
figure (a) the action potentials are plotted without the
presence of any drug. From figure (b) to (f) the action
potentials are plotted for kson=0.001, 0.01, 0.05, 0.1
and 0.5 with A= 200 µm2, Iext = 6.9 µA/cm
2 and
reopening flux, FSB= 0.001 ms
−1. In all the cases
where Na-blocker is present the action potential train
ultimately dies off, sooner for higher affinity(not shown
for (b) and (c) as they require more than 20,000 ms,
plotting them makes the plots compact and clumsy, the
train dies off similarly as shown in (d)-(f)).
shown the effect of sodium channel blockers on action po-
tentials train with time with increasing drug affinity or
concentration. It is seen that in presence of drug the spik-
ing activity gradually dies off temporally. With increas-
ing affinity the spiking activity dies off in a faster rate.
As seen from figure 3(f) at very high value of kson = 0.5
the system almost fails to regenerate action potentials.
As the affinity increases more channels quickly go to the
drug-bound state and gets trapped in the drug bound
state. Thus the available open sodium channels gradu-
ally decreases which makes it difficult for that particular
patch to generate action potential. Beyond kson = 1.0
we have seen that the patch totally fails to generate even
7a single spike after the first spike.
B. Only Potassium Channels Are Blocked
Next we have studied the effect of open state potassium
channel blockers on the action potential generation. Here
the DP state is only considered, not DS state. In fig-
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FIG. 4: Effect of potassium channel only
blockers: Action potentials in various blocking
affinities of potassium only blockers are plotted here. In
figure (a) the action potentials are plotted without the
presence of any drug. From figure (b) to (f) the action
potentials are plotted for kpon = 0.0001, 0.001, 0.005,
0.01 and 0.1 for A = 200 µm2, Iext = 6.9 µA/cm
2 and
reopening flux, FPB = 0.001 ms
−1. Although here also
action potential dies off temporally but the nature of
termination is quite different from that of the sodium
channel only blocker.
ure (4) the action potentials for various kpon are plotted.
Here also for all the cases where drug is present ultimately
the spiking activity of the action potential dies off tem-
porally. As usual with increasing affinity the blocking of
action potential occurs in a faster rate. But, surprisingly
here we have observed an interesting trend of action po-
tential termination which is quite different from sodium
blocking case.
If we carefully notice the spikes in figures (3) and (4)
at high affinity regions, we can see that in presence of
sodium channel blockers the number of generated action
potentials although decreases down significantly, but ev-
ery spike has a complete shape(they depolarize > repo-
larize > hyperpolarize > again comes back to resting po-
tential). But for potassium blocking case we see that
after a few millisecond the spiking activity entirely falls
off with the last spike having incomplete shape. This
happens due to lack of available open potassium chan-
nels. Due to the lack of available open potassium chan-
nels the repolarization process gets hampered, leading to
the incomplete generation of action potential. Once it is
not complete further generation of action potential is not
possible as the refactorization process which was neces-
sary for further generation of action potential could not
complete. Thus no action potential generation can take
place further as seen from figures 4(d-f). But in case of
sodium channels there remains plenty of available potas-
sium channels which can restore the depolarized potential
back to the resting one. Thus in sodium blocking case the
spikes generate with complete shape even if there number
decreases with increasing affinity.
IV. EFFECT OF THE CHANNEL BLOCKERS
In this section we have shown how the sodium and
potassium channel blockers and local anesthetics(dual
type blockers) affect the ionic current, spiking frequency,
duration of the action potential and gating dynamics, all
of which plays physiologically very significant roles.
A. Ionic Current
The sodium and potassium ionic currents across the
membrane are given by the eqution (8). Now here we
would like to point out that although sodium and potas-
sium channels are two different proteins, during an action
potential, they work together and thus sodium and potas-
sium currents have interdeppendent relationship. The
number of spikes of sodium ionic current is equal to the
number of spikes of potassium ionic current. Hampering
sodium channel conductance with sodium channel block-
ers may not directly affect the gating mechanism inside
the potassium channel proteins, but the decreased effi-
ciency of conductance leads to decrease in the number
of sodium ions coming inside and thus less number of
potassium ions are required go out side to balance that
depolarization, leading to a decrease in the magnitude of
potassium current too. On the other hand if we keep on
decreasing the ionic conductance of potassium channels
by applying potassium blockers, the repolarization pro-
8cess or refactorization process would gradually get ham-
pered which in turn will also affect the membrane po-
tential which eventually becomes unsuitable for sodium
channels to open as we have seen from figure (4). Thus
both of the currents are affected if anyone of them is
disturbed.
Now in figure (5) we have shown the interdependent
nature of sodium and potassium currents and how the
currents are being affected in presence of ion channel
blockers with increasing drug binding affinity. The cur-
rents are generated in response to a change in the respec-
tive ion channel conductances. The total number of Na+
or K+ ions that permeate inside or outside the membrane
during the action potential is proportional to the areas
under the individual current curves in the figures.
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FIG. 5: Ionic current: In this figure we have plotted
the sodium and potassium channel ionic currents
together with their corresponding action potentials. In
the left panel, figure (a), the effect of sodium channel
only blockers with affinity, kson= 0.05, 0.5 are
compared with the case where no drug is present. The
top trace represents the potassium ionic current and the
bottom trace represents the corresponding sodium ionic
current. In the right panel similar plot has been shown
with potassium only blockers. A= 200 µm2 and
Iext = 6.9 µA/cm
2. Both the blockers have different
signatures of blocking.
The red dotted curves in each traces of figure 5(a) rep-
resents the case of drug free situation. After the first
spike the loop area shrinks. Afterwards the area of ionic
currents slightly change due to the presence of the fluc-
tuation in the number of available open channels which
creates the broadening of the band. The blue dot-dashed
curve for affinity kson=0.05 and and black-solid line for
kson= 0.5 shows that both of the ionic currents gradu-
ally shrinks over time. If we plot in a 3D diagram with
membrane depolarization in x axis, currents in y axis and
time in z axis we see that with increasing time the area
of the ionic currents shrink gradually with corresponding
decrease in the peak height of the action potentials. This
shows the gradual decrease of sodium ion influx inside the
cell membrane.
Next we have observed an interesting feature of potas-
sium channel blocking on both the ionic currents. Un-
like the case of sodium blockers in 5(a), here we see
that the loop area of both the ionic currents falls down
very rapidly covering the entire space which indicates
the decrease in the potassium channel conductance over
time. Unlike the sodium only blockers, the correspond-
ing action potential magnitude is much higher here when
the currents fall down to zero. This once again clearly
says that the membrane repolarization process is dras-
tically hampered. As the loop areas are proportional
to the number of ions being permitted across the mem-
brane, the potassium only blockers show this amount is
hampered more rapidly than sodium blockers of equal
affinity. The effect of blockers on effective ionic current,
Iint = INa + IK + IL over the corresponding action po-
tentials can also be found in the supplemental materiel
figure (S1).
B. Spiking Frequency
Next we have studied the effect of the two types of
blockers on the spiking frequency of the action potentials
with increasing kxon in figure 6(a). Here we have found
an interesting difference of spiking frequency trends be-
tween sodium and potassium blockers. It is seen that in
presence of sodium channel blockers the spiking rate falls
off exponentially with increasing affinity. But in presence
of potassium channel blockers the spiking frequency ini-
tially with increasing kpon increases unlike sodium chan-
nel and then it decreases. This initial increase in spiking
activity in presence of potassium blockers is consistent
with the earlier works done in literature [24, 46]. This
happens because with the increase in affinity number of
potassium channels decrease which causes an increase in
the internal noise and therefore channel number fluctua-
tion starts playing significant role by spontaneously gen-
erating action potentials, as we have already seen from
the figure(2). Actually in presence of potassium blockers
there exists a competition between the overall conduc-
tance of the ions and the channel noise. In the low affin-
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FIG. 6: Spiking frequency: In figure (a) the spiking
frequency(Hz) of the action potentials in presence of
increasing sodium and potassium channel only blocking
affinity, kson and kpon have been plotted respectively,
ranging from 0.0001 to 0.07. The spiking frequency is
calculated over a long simulation run upto 20s. The
squared-(black)-solid line and the diamond-(red)-dashed
line shows the frequency of spiking of action potentials
in presence of only sodium and potassium channel
blockers, respectively. In figure (b) the spiking
frequency profile is plotted for the dual type blockers
for the cases: (i) kson > kpon: squared-(black)-solid
line, (ii) kpon > kson: circled-(red)-dashed line and for
(iii) kson = kpon: diamond-(blue)-dot dashed line. For
all the cases A = 200 µm2 and Iext = 6.9 µA/cm
2 and
those spikes are only considered which have peak
heights more than -10 mV.
ity region the influence of the channel noise dominates
over the ion conduction and thus the spiking activity in-
creases. After a certain kpon value, the spiking activity
decreases as the decreased overall conductance dominates
here. For sodium channel only blockers, the over all con-
ductance always dominates over channel noise.
C. Action Potential Duration
Next we have seen the effect of channel blockers on
the action potential duration(APD) itself. APD varies
from one neuron to another neuron type. Any alter-
ation of APD of a particular neuron can lead to sig-
nificant complexities in signal transmission process and
can give rise to critical physiological disorders. We have
found that in presence of blockers APD significantly al-
ters with time. First we have chosen three drug affinity
regions such as low, medium and high, corresponding to
the sodium and potassium blocking. For sodium block-
ers we have chosen the affinities, kson= 0.005(low), 0.05
(medium) and 0.1(high). For potassium blockers we have
chosen the affinities, kpon = 0.005(low), 0.01 (medium)
and 0.05(high). The regions are different because with
the same magnitude of affinity potassium blockers affect
the spiking activity more rapidly than sodium blockers as
seen comparing figures (3) and (4). Next for each affinity
we have arbitrarily chosen a spike from few initial spikes
and then compared it to the randomly selected spikes
from intermediate and end positions of the spike trains
and plotted them in a same scale.
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FIG. 7: Action potential duration: The temporal
change of APD in presence of ion channel blockers have
been shown here. In the top traces, (a-c), the initial,
intermediate and end point spikes are plotted in a same
scale for sodium channel only blockers with affinity kson
= 0.005(low), 0.05(medium) and 0.1(high ). In bottom
traces, (d-f) similar plots have been done for potassium
channel only blockers with affinities, kpon = 0.005(low),
0.01 (medium) and 0.05(high). In both cases, A= 200
µm2 and Iext = 6.9 µA/cm
2. The green-solid arrows are
indicating the direction of shortening or broadening of
the incoming action potential.
From figure (7) we have again found an interesting dif-
ference in APD for two types of blockers. It is seen that
for sodium channel only blockers with increasing time
the repolarization process gets faster or the shortening
of the APD occurs where as contrastingly, for potas-
sium blockers the repolarization phase is seen to be de-
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layed considerably with increasing APD. The shortening
of APD in presence of sodium blocker happens because
the effective number of sodium ions are entering the cell
decreases with time and thus less number of potassium
ions required to go out to bring back the repolarization
which thus gradually takes lesser time than usual. On the
other hand in presence of potassium blockers the repo-
larization phase is seen to be delayed temporally because
the number of available open potassium channels gradu-
ally decrease and thus the repolarization brought by the
decreased number of channels take longer time. Thus
the broadening of APD occurs gradually. This shorten-
ing or the broadening of the APD is actually a special
characteristic feature of sodium and potassium channel
blockers respectively which have great physiological sig-
nificance and clinical use. Patients with longer or shorter
APD due to mutagenic, hereditary or other physiological
conditions are treated with ion channel blockers.
Dual Blockers
Here we want to point out that some ion channel block-
ers such as local anesthetics are well known for their
non-specific blocking nature. Also at an elevated con-
centration some drugs that primarily target Na chan-
nel may also seen to affect K channels. Channel spe-
cific type of blocking as discussed so far is more pro-
nounced for TTX(specifically binds to Na channel only)
and TEA(binds to potassium channel only) types of
blockers only which are mostly used in experimental re-
searches. But for local anesthetics or clinically used drugs
we must consider both type of blocking simultaneously.
For that purpose we have chosen three types of block-
ing schemes which summarizes all possible kinds of non-
specific binding mechanisms. For the first case we have
kept both the sodium(kson) and potassium(kpon) drug
binding affinities equal, i.e, kson = kpon. So these rep-
resents those class of drugs which binds to both type
of channels with equal affinities. For the second case
we have chosen those types of drugs which have ap-
proximately 10 times higher affinity of blocking sodium
channels[12]. The major difference between local anes-
thetic action in K+ currents compared with Na+ cur-
rents is the lower affinity(approximately 10 times lower)
in the former[12]. So here we have kept the sodium block-
ing affinity, kson > kpon ≈ 10 times. Finally we kept
kpon > kson ≈ 10 times. One can change the ratio ac-
cording to the need or according to the knowledge of the
binding affinity of a particular drug. The figures of ac-
tion potential trains for these three categories of blocking
can be found in the supplemental figures (S2), (S3) and
(S4).
Spiking Frequency: Now we have plotted the spik-
ing frequency profile for these three cases in figure 6(b).
For the case of kson = kpon(diamond-blue-dot-dashed
line) it is seen that initially frequency decreases up to
around kson=kpon=0.001 and then passing through a
minimum it increases between a small region upto around
0.004 and then a large decrease is observed until 0.01 is
reached. After that again an increase in frequency is ob-
served until 0.03 and then it falls off gradually. These sort
of double minimum and maximum in frequency of spiking
actually indicates a competition between overall sodium
and potassium ionic and channel noise activity. The re-
gions where the maxima exist are basically the regions
where the channel number induced spontaneous spiking
activity dominates on overall ion conductance[24]. In
other words it can be said that the maximums arise due
to the coherence resonance due to channel noise[23]. For
the other two cases such as kson/kpon ≈ 10(squared-
black-solid line) and kpon/kson ≈ 10(circled-red-dashed
line), the previous trends of sodium and potassium only
blockers are observed as seen from figure 6(a). The case
of kson = kpon is different which indeed reduces to the
other two cases when the ratios become 10. However,
for all the three cases it is seen that the action potential
generation gradually ceases off with an the unsuitable
refactorization potential which clearly indicates that to-
wards the end of the action potential train, potassium
channel blocking plays more influential role in the action
potential termination process.
Action Potential Duration: Next we have plotted
the effect of these three types of drug blocking mecha-
nisms on the duration of the action potential in figure
(8) over one individual action potential train. For the
kson > kpon case(the middle trace), we have found that
initially the APD shortening occurs for few ms due to the
dominant(kson 10 times stronger than kpon) blocking of
sodium channels over potassium channels. But shortly
after when sufficient amount of potassium channels are
blocked, the effect of potassium blocking starts playing
significant role by delaying APD. The inward arrow in
the middle trace of figure (8) shows the shortening of
APD followed by an outward arrow indicating the grad-
ual delay of APD as time progresses. We have verified
this for all affinity region. For higher affinity region, such
11
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FIG. 8: Action potential duration affected by
dual blockers: The change in the duration of the
action potential in presence of local anesthetic channel
blockers at a higher affinity over their individual course
of action potntial train have been plotted for the cases
kson = kpon(left), kson > kpon(middle) and
kpon > kson(right). The approximate positions of the
five randomly chosen spikes over a train of action
potential simulation run of t ms are shown in the inset
of middle figure. Here also A= 200 µm2 and Iext = 6.9
µA/cm2.
as kson = 0.1, the broadening of APD occurs, preceded
by a quick APD shortening. However, here we want to
point out that the shape of action potentials in this case
have been found to be heavily affected such as the grad-
ual decrease of the peak height of action potentials as
time progresses(see supplemental figure S3). Keeping the
peaks fixed we have found that the initial upward depo-
larization phase of action potentials also changes signif-
icantly, as seen in the left portion of the peak in the
middle trace. So the change of APD here, particularly
in this case is considered as the peak after shortening or
broadening. In the right trace, the case kpon > kson is
shown which shows exactly similar nature of APD broad-
ening as shown in potassium channel only blocking case
in figures 7(d-f). For the kson = kpon case in left trace,
although the frequency response curve came up with dif-
ferent signature but for the duration of the action po-
tential it basically displays the potassium blocking dom-
inance by delaying action potential duration. Following
Table(II) summarizes our results:
D. Gating Dynamics
Here we have studied the percentage of the total pop-
ulation of channels present at a particular time in dif-
ferent conformational states including the drug bound
state. In the left traces of figure (9) the population(%)
for sodium only blockers for affinity, kson= 0.1 and the
corresponding population(%) of potassium channel states
has been shown in right traces. Observing both the traces
we find that each of the action potential spike is associ-
ated with either upward or downward spike in all the
population plots, both for sodium and potassium con-
formational states. This indicates that sudden random
action potential generation is associated with sudden dra-
matic changes of the entire population occupancy of all
the conformational states. From the left trace of figure
(9) we see that in 20 seconds( although spikes occurring
ceases long ago) only ∼50% channels are trapped in drug
bound state, DS which slowly increases with time. The
rest of the population is mainly trapped in the inactive
states and closed states. With increasing affinity the drug
bound state populates in a faster rate.
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FIG. 9: Gating dynamics in presence of sodium
only blocker: The action potential and the
corresponding population of every sodium(left traces)
and potassium(right traces) channel conformational
states are plotted for sodium channel only blocker with
kson= 0.1 at A= 200.0 µm
2 and Iext= 6.9 µA/cm
2.
Next we have plotted every population(%) of the
sodium and potassium channel states in presence of
potassium only blockers in left and right traces of fig-
ure (10) respectively for kpon = 0.1. It is very aston-
ishing to see that the trends of population dynamics
has been drastically changed from that of the sodium
only blockers in figure (9). They show different occu-
pancy dynamics. It clearly says that different types of
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Blocking mechanism Spiking Frequency APD
Sodium channel only blocking Exponential decrease Shortening occurs
Potassium channel only blocking Initially increase and then decrese Broadening occurs
Equal affinity :kson = kpon Maxima and minima arises Broadening occurs(potassium blocking dominates)
Preferential sodium blocking :kson > kpon Exponential decrease APD shortens initially, then broadening occurs
Preferential potassium blocking :kson < kpon Initially increase and then decrese Broadening occurs
TABLE II: Various blocking mechanism and their effect on spiking frequency and action potential duration(APD).
blocking agents can considerably change the gating dy-
namics of the system. This inference is consistent with
the earlier literature[13, 47]. It is a very important re-
alization which could be obtained only from a Markov
model oriented studies like this. Another interesting fea-
ture is that the population of the drug bound state, DP
very rapidly grows towards 100% for kon=0.1, unlike the
sodium only blocking. The sodium channel population
is mostly trapped in m3h0 state, which is a closed state.
The altered gating dynamics and hampered membrane
potential originating from disrupted ion conduction in
presence of blockers make them trapped in this state, as
already discussed in Section III. This is a cross verifica-
tion of our previous statement.
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FIG. 10: Gating dynamics in presence of
potassium only blocker: The action potential and
the corresponding population(%) of every sodium(left
traces) and potassium(right traces) channel
conformational states are plotted for potassium only
blocker with kon= 0.1 at A= 200.0 µm
2 and Iext= 6.9
µA/cm2.
V. OUR KINETIC DRUG BLOCKING MODEL
VERSUS OTHER STUDIES IN THE
LITERATURE
Hodgkin-Huxley squid axon model is a very basic rep-
resentation of a neuronal cell. Since 1952 many Markov
models with more coupled states or more complexities
have come up that mimic the biological responses more
accurately. But due to the diverse nature of living cell
types there exist different types of models for differ-
ent systems. In this paper our goal is to understand
kinetically how the ion channel blockers affect a neu-
ronal cell, in general. Besides it is simply not possible
to study all kinds of model and compare them. As we
are looking at two criteria mainly: the variety of firing
rate dynamics that can be reproduced and the shape of
action potentials affected by ion channel blockers, the
Hodgkin-Huxley(HH) model is a well accepted model[48]
in this regard compared to threshold models such as
the Leaky Integrate and Fire(LIF)[49] or the Izhike-
vich model(IZH) [50], Morris-Lecar model[51], FitzHuge-
Nugamo(FHN)[52] because the parameters of the HH
model have biophysical significance. Moreover one can
modify the original model parameters to easily include
the cell response of different systems[53]. The stochastic
drug binding approach on HH model is a very good choice
since it is capable of bringing out the essential physiolog-
ical features of ion channel blocking phenomena which
corresponds to many experimental observations till date
tested on different types of systems. In the following we
present the references of such experiments done.
1. Broadening of APD: From the study of potas-
sium only blockers and the local anesthetic block-
ing that have more blocking potency to potassium
channel than sodium blockers(case of kpon > kson),
we have seen that these blockers tend to broaden
or delay the action potential duration. There
exist lots of experimental evidences that support
this finding. TEA, 4-AP(4-Aminopyridine), CTX
13
(charybdotoxin) etc mainly known for potassium
channel blocking potency show broadening of ac-
tion potential in demyelinated rat sciatic nerve[46],
rat hippocampal pyramidal cell[26], rat superior
cervical sympathetic neurons[27], on supraoptic
neurons[28], on Hippocampal CA3 Neurons[29] and
mammalian central neurons[30]. The effect of Den-
drotoxin, a potassium blocker from mamba snakes,
on cerebellar basket cells, has also shown a delayed
action potential duration[31].
2. Multiple spike discharge: It is also verified that
4-AP can lead to multiple spike discharge, spon-
taneous impulse activity and alteration of refrac-
tory periods[46]. These results are totally con-
sistent with our frequency response curves in fig-
ure (6) and action potential plots in presence of
potassium blockers. From the figure 4(b) and
(c) we can also see that the spike train shows
sudden spontaneous and enhanced spiking density
temporally(spike train seen to be very dense) as
also seen in ERG-K+ channel blockade[32] and
ABP(Ankyrin-binding peptide) blockade on Neu-
ral KCNQ(Kv7) channels[33]. The effect of chan-
nel blockers on effective ionic current loop is also
consistent with literature[29].
3. Shortening of APD: On the other hand the
shortening of action potential duration in presence
of sodium channel blockers is more pronounced
for cardiac cells, as far as our literature survey
is concerned. Shortening of the action potential
by ion channel blockers has been observed in sev-
eral systems like sheep cardiac purkinje fibers[34],
in rabbit cardiac Purkinje fibers[35], in dog ven-
tricular cardiomyocytes[36], in guinea pig ventric-
ular myocytes[37] etc. Antiarrhythmic agents such
as Lidocaine, Phenytoin, Mexiletine, Tocainide etc
sodium channel blockers shortens the action poten-
tial duration[38]. Antiarrhythmic agents such as
bretylium, amiodarone, ibutilide, sotalol etc pre-
dominantly block the potassium channels, thereby
prolonging repolarization[38]. The mechanism of
cardiac cells are quiet different due to the presence
of other important types of ion channels and also
the shape and length of action potential is quite
different than neuronal cell . We do not compare
our simple Hodgkin-Huxley action potential result
to the cardiac action potentials. Hodgkin-Huxley
model shows good agreement with the neuronal
cells. We just mention that cardiac cells also show
similar effects as the neuronal cells show in presence
of channel blockers.
4. Altered gating dynamics: The state transi-
tions that underlay the gating process(opening,
closing or inactivation etc) are altered by local
anesthetics[13] and that such altered gating itself
becomes the essential modulator of local anesthetic
block[47]. From the results discussed for gating dy-
namics in figure (9) and (10), we have also shown
that the sodium and potassium blockers have very
distinct population dynamics. Thus both type of
drugs drastically change the gating dynamics.
A. Comparison Between Langevin and Markov
Model Simulation
The transient properties such as spiking interval, co-
efficient of variation of spiking due to channel block-
ers has been studied using Langevin description of
stochasticity[24] in HH model. Here we have provided a
brief comparative study between the original determinis-
tic description of HH model using gating variables(m,h,n
without white noise terms added), Langevin descrip-
tion(equation 3) used in reference [24] and our Gillespie
simulation of HH-Markov chain model used in this pa-
per. Ignoring the channel noise fluctuation we want to
see how close the Langevin[24] and Gillespie simulation
we adapted matches each other with or without the pres-
ence of blockers. In Langevin description the dynamics
of the gating variables are considered to be stochastic as
follows,
z˙ = αz(V )(1 − z)− βz(V )z + ηz(t), (3)
where z = n,m, h. n represents the potassium andm and
h together represents sodium gating dynamics as consid-
ered by Hodghkin-Huxley originally. ηz(t)(s) are inde-
pendent Gaussian white noise which makes the sodium
and potassium gating dynamics stochastic in nature. The
strength of the individual noises are given as follows[24]:
< ηz(t)ηz(t
′) >=
2
Ni
αz(V )βz(V )
[αz(V ) + βz(V )]
δ(t− t′), (4)
where i = NNa for z=m and h and i = NK for z=n. The
blocking of sodium and potassium channel conductance
are considered as fractional conductance[24] as follows,
GK(V, t) = g
max
K xKn
4 and GNa(V, t) = g
max
Na xNam
3h,
(5)
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where the factors xK and xNa are the fractions of working
or unblocked ion channels to the overall number of potas-
sium and sodium channels, respectively. 0 < xK/Na ≤ 1.
Solving the conductance equation (5) and equation (1)
one obtains the action potential using this Langevin type
of description.
Similarity: From figure 11(a) it is seen that with-
out the presence of drug and stimulus both Langevin
and Markov description matches the deterministic-HH
description when channel number fluctuation is ignored
with high patch size which also validates that our
simulation-code results to be correct. Next in figure (b)
we have shown that the Gillespie and Langevin model
even in presence of stimulus, matches each other when
the channel noise is ignored. However as the external
current is applied the determiistic match requires higher
patch size, such as A= 20,000 µm2. Next, in figure (c) we
have compared the models in presence of high drug bind-
ing affinity(for example, we showed the potassium block-
ing case here only). In high patch size where the channel
noise is ignored it is expected that the Langevin approach
should produce similar result to that of the model we con-
sidered having high drug binding affinity. Now as seen
from figure(c), we find that for obvious reason the origi-
nal deterministic-HH description matches with Langevin
description exactly showing that the action potentials, at
this very high blockade region(xK=0.1), quickly damps
down and as the refactorization is hampered no further
spikes could regenerate. Now this result is compared to
the very high affinity region of our model with kpon=0.5.
We can see that the Langevin simulation shows simi-
lar trend of action potential termination as our Markov
model does. Although they do not match each other ex-
actly, not expected to match each other either(blocking
schemes are very different) but their nature is mostly
same. Thus our model reduces to the Langevin model
to an extent. The difference in the termination poten-
tial arises due to their inherent model differences. The
termination potential in Langevin scheme is around -30
mV which is also unsuitable for further action potential
generation.
Difference: The difference between the Langevin
scheme and our Markov scheme of drug binding is that
the Langevin scheme discards a certain fraction of the
total number of sodium or potassium channel and their
contribution to the total conduction from the patch at
the very beginning. The action potentials are then cal-
culated on the basis of remaining number of available
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FIG. 11: Comparison between original
Deterministic-HH, Stochastic Langevin and
Markov-Gillespie drug binding schemes: channel
noise ignored: In figure (a) the action potential
generated from Deterministic-HH, Langevin and
Markovian simulations has been compared with out the
presence of drug and external current and channel
noise. In figure (b) similar plot has been done in
presence of an external current. In figure (c) we have
compared three results in presence of very high
potassium channel blocking affinity.
channels, thereby assuming that during the time of ob-
servation, the number of blocked channels do not change,
or as if the drug binding kinetics is in a standby mode.
Actually in real situation during the course of obser-
vation the available number of open channels or num-
ber of blocked channels change due to the drug binding.
With higher affinity the channels are blocked in a faster
rate and vice verse. This is the main reason why the
Langevin approach can not show the gradual change in
shape or APD with time. As the Langevin approach does
not have any specific states of the channel(closed, open
or inactivated state etc) a lot of information regarding
the population dynamics, altered gating dynamics is lost
which makes our Markov model approach a better alter-
native for studying kinetic drug blocking model. Most
importantly, the intricate details of various drug binding
schemes such as closed or inactivated state blocking etc
can also be adapted and implemented using simple con-
sideration of suitable drug-bound states which are not
possible in the Langevin approach. Also the Gillespie
simulation of Markov model gives the opportunity to cal-
culate the population of individual states which opens the
door of carrying out various nonequilibrium thermody-
namical analysis[54, 55] such as entropy production rates,
free energy change etc of different binding schemes also.
In short our Markov model based study has some ad-
vantages over Langevin approach in the context of state
specific ion channel blockade.
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VI. CONCLUSION
The definite presentation of specific channel states in
the Markov model helps to describe not only the macro-
scopic current contributing for the action potential, but
also the probability and transitions of each channel state,
which gives a mechanistic and detailed link between the
whole-cell action potential and the structure or function
of ion channels. Thus Markovian simulation is an essen-
tial part of modern day model based elcetrophysiological
and pharmaceutical investigations. Here we have tried
to understand how one can theoretically bring out the
essential features of ion channel blocking. By the suit-
able adaption of Gillespie algorithm along with the direct
numerical simulation of voltage dynamics we have been
able to show how a simple extension of Hodgkin-Huxley
model can prove to be an important tool to understand
the effect of ion channel blockers to predict the impor-
tant drug binding features like altered spiking frequency,
altered duration of action potential of a neuronal cell and
altered gating dynamics etc. This study establishes a link
between the theoretical understanding of drug binding
kinetics and the observed experimental findings[26–38].
Our study gives an opportunity to further investigate dif-
ferent types of drug binding features that can originate
from other types of drugs such as closed state blockers
or inactive-state blockers. The major conclusions of this
study in kinetic drug binding scenario is as follows.
1. In the case of only sodium channel blocking al-
though the spiking activity decreases with blocking
affinity, the train of action potentials generated are
of complete shape because there are plenty of ac-
tive potassium channels available to bring the sys-
tem back to its resting state. However, in case of
potassium blocking at higher value of binding affin-
ity, due to the lack of active potassium channels
the shape of action potential at the end can not
complete. Consequently the re-factorization pro-
cess gets hampered which eventually affects the
sodium channel activation process to regenerate
more spiking activity. In case of sodium channel
blockers spiking activity slowly decreases mainly
due to absence of adequate number of available
open sodium channels, where as in case of potas-
sium channel blockers the repolarization leading to
re-factorization process plays a vital role in destroy-
ing spike generation process.
2. We have also shown two distinct types of spik-
ing trends in presence of two types of blockers.
For sodium blocker we observe that the spiking
frequency falls off exponentially with the increas-
ing binding affinity. In contrast, with increasing
potassium blocking affinity, initially the spiking fre-
quency increases towards a maximum and then it
gradually falls off exponentially. This initial in-
crease in spiking activity arises due to the domi-
nance of increased internal potassium channel num-
ber fluctuations or channel noise over total ionic
conductances. In case of local anesthetics or dual
blockers where the drugs have equal binding affin-
ity to both the channels, show multiple maxima in
spiking frequency trend. A drug with more binding
affinity to a particular channel shows similar spik-
ing frequency trends as in the case of only sodium
or potassium blockers. However there exists a crit-
ical value of affinity for potassium channels above
which irrespective of mechanisms all spiking activ-
ity is destroyed due to incomplete re-factorization
process.
3. Both the sodium and potassium blocking agents
considerably changes the gating and population dy-
namics of the system which we could show using our
description.
4. Our approach satisfactorily agrees as well as pro-
vides suitable explanation regarding the experi-
mentally observed change in action potential du-
ration in presence of channel blockers. Sodium
channel blockers shorten the action potential dura-
tion and the potassium blockers delays it. However
in case of dual type blockers we have shown that
potassium blockers play influential role by prolong-
ing the repolarization process ultimately.
Thus using our basic mechanisms of ion channel block-
ing one can develop a systematic understanding of the
physiological effects of channel blockers for simple neu-
ronal cell with sufficient details which opens the possi-
bility of exploring many other important drug binding
features with the incorporation of desired level of struc-
tural and functional details.
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Appendix
A1: Gillespie Algorithm for Site Selective Ion
Channel Blocking
To consider site selective binding of sodium or potas-
sium blockers in a single neuron the Gillespie’s algorithm
we used to study the drug binding kinetics has been
implemented using the following steps.
1. Initially we have fixed the number of sodium and
potassium channels to be simulated. NNa = ρNaA and
NK = ρKA are the numbers of sodium and potassium
ion channels in a particular patch of area A µm2 with
sodium channel density, ρNa= 60 µm
−2 and potassium
channel density, ρK= 18 µm
−2[23] .
2. Then at a resting membrane potential, i.e. at -
70 mV the steady state values of the gating variables
n,m and h are solved using the following steady state
equations[17],
n =
αn
αn + βn
,m =
αm
αm + βm
and h =
αh
αh + βh
. (6)
3. Next at t=0 we have assigned the population of the
drug-bound state, DNa/K = 0 for respective sodium and
potassium blocker simulations. All the other 13 states
are binomially distributed[40],
NkjNa =
(
3
j
)
hk(1 − h)(1−k)mj(1 −m)(3−j)NNa,
N jK =
(
4
j
)
nj(1 − n)(4−j)NK , (7)
where NkjNa and N
j
K denotes the population of the states
where k number of h gates, j number of m gates for
sodium channel and j number of n gates for potassium
channels are open. Here NkjNa and N
j
K are integers which
fluctuate around their expected values.
4. Then we put an initial voltage of -60 mV and start
the simulation for a paticular value of Iext. First we
calculate the individual propensities, aK(nj → nj′) for
potassium ion channel and aNa(mjhk → mj′hk′) for
sodium channels of all the 30 reactions (including the
drug-bound state). Here (mjhk → mh′kj′) or (nj → nj′)
indicates the transition between neighboring states. The
propensities aNa(mjhk → mj′hk′) or aK(nj → nj′ ) for
individual transitions are expressed as the transition rate
multiplied by the population of the state from which the
transition is taking place. As for example, the transi-
tion from the state m1h0 to m2h0 has the propensity,
aNa(m1h0 → m2h0) = 2αmNm1h0 . Similarly for potas-
sium channel the propensity for the transition between
n3 to n4 is given by, aK(n3 → n4) = 2αnNn3 . Only the
backward transitions from DNa or DK , the propensities
has been given a constant value as mentioned earlier.
This way we calculate 30 propensities corresponding to
30 reactions.
5. Next we calculate the total propensity, aT by sum-
ming over all the propensities as calculated in the previ-
ous step. The sum can be expressed simply for sodium
channel blockers as,
aT =
[
22∑
ν=1
aνNa
]
+
[
8∑
ν=1
aνK
]
.
and for potassium channel blockers,
aT =
[
20∑
ν=1
aνNa
]
+
[
10∑
ν=1
aνK
]
.
6. Next we calculate the random time required for the
next transition to occur by calculating τ , given as
τ =
1
aT
ln(1/r1),
where r1 is a pseudo-random number called from an uni-
form distribution[0,1]. As soon as the τ is obtained, the
time is incremented by t = t+ τ .
7. In the next step we calculate which one of the 30
reactions has taken place in that τ time. An integer µ
is assigned which designates the transition number. So
µ varies from 1 to 30 in our case including the drug-
binding step. Then another random number, r2 from an
uniform distribution[0,1] of unit interval is called. Then
we calculate the quantity, (r2× aT ). Then the transition
number µ is calculated using the following relation
µ−1∑
ν=1
aνNa/K < (r2 × aT ) ≤
µ∑
ν=1
aνNa/K .
This is actually adding the successive propensities, such
as aNa(m0h0 → m1h0) + aNa(m1h0 → m0h0) +
aNa(m1h0 → m2h0) + aNa(m2h0 → m1h0) + ..... +
aK(n0 → n1) + aK(n1 → n0) + aK(n1 → n2) + aK(n2 →
n1)+.... under the µ do-loop (µ = 1 to 30) until their sum
is equal or just exceed (r2 × aT ), and the loop number
index or the transition index, µ is then set equal to the
loop index or transition number index of the last aν term
added. This is how the reaction taken place is identified.
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8. As soon as the reaction number index, µ is iden-
tified, the population of the states associated with that
reaction is updated by ±1. The population of the state
from which the transition occurred is updated with -1
and the population of the state where to the transition
has occurred is updated with +1.
9. Then the sodium and potassium conductances
are calculated using equation 2 and the corresponding
sodium,INa and potassium , IK ionic currents are given
by the equation
IK = GK(V, t)(V −EK) and INa = GNa(t)(V−ENa).
(8)
10. Then membrane potential is simply integrated
with the calculated time step τ as follows,
Vi = Vi−1 +
1
Cm
[(Iext − Iint)τ ] ,
where Iint = IK + INa + IL.
11. Then again the process is repeated from step 4,
with the new value of membrane potential and updated
transition rates and propensities at the obtained value of
membrane potential, V.
12. To calculate the spike frequency of action poten-
tials we run the program for a very long time and then
convert the spike number in Hz unit.
Using the above mentioned algorithm we have written
a Fortran 90 code and complied in GFORTRAN to
study the physiological effect of drug binding on action
potentials.
A2: Time Dependent Propensity vs. Constant
Propensity
Here we want to mention that the method that we
have adapted for the calculation of the propensities
is a very popular and widely used method and of-
ten claimed to be an exact method for simulating ac-
tion potenial using Gillespie algorithm. However con-
trary to this popular belief this method is not an ex-
act method. In systems where the rate constants or
the transition rates are time dependent through volt-
age change[kz(V (t)), k = α or β, z = m,n, h] or change
with time due to temperature change or volume change,
propensity functions does not remain constant between
reactions, i.e. aνNa/K(t) = a
ν
Na/K(X(t), t), where X(t) =
{[m0h0](t), .., [m3h1](t), [n0](t), .., [n4](t)} is the popula-
tion state vector of different states[56]. When the propen-
sity functions depend only on the state of the system i.e.
aνNa/K(t) = a
ν
Na/K(X(t)) the Gillespie algorithm calcu-
lates the time until the next transition takes place by
considering the first transition time of Rν(total number
of transitions) time homogeneous transitions. How-
ever, as the transition rates become time dependent,
the first firing time has to be calculated from Rν time-
inhomogeneous transitions. The amount of time that
must pass until the next transition takes place, τ , is given
by the distribution function[56]:
1− exp
(
−
Rν∑
ν=1
∫ t+τ
t
aνNa/K(X(t), s)ds
)
, (9)
where X(t) is constant in the above integrals as no reac-
tions take place within the time interval [t, t+ τ). Using
the above equation, τ is obtained by first letting r1 be
uniform(0,1) and then solving the following equation:
Rν∑
ν=1
∫ t+τ
t
aνNa/K(X(t), s)ds = ln(1/r1). (10)
Then the transition that occurs at that time is chosen
according to the probabilities[56] aνNa/K(X(t), t+ τ)/aT ,
where aT =
∑Rν
ν=1 a
ν
Na/K(X(t), t + τ). So it is seen
that this time dependent case is very different from
the time homogeneous case which are most frequently
used in literature where τ is exponentially distributed as
P (τ) = aT (X(t) exp
[
− aT (X(t))τ
]
, where aT (X(t)) =∑Rν
ν=1 a
ν
Na/K(X(t)) and the probability that the next re-
action is ν-th reaction is given as aνNa/K(X(t))/aT (X(t)).
However, solving equation(10) by both analytically and
numerically is extremely hard and time consuming. Ow-
ing to the difficulty of solving equation (10) one can by-
pass it by using next reaction method or modified next
reaction method[56]. However those methods are also
restricted to very few number of channels. The rigorous
Gillespie algorithm remains a challenge for the stochastic
Hodgkin-Huxley model. For very low patch size where
very few number of channels are considered the Gille-
spie algorithm with constant propensity assumption is
very questionable, indeed it is wrong. However, for many
channels with very large total propensity of a large popu-
lation of channels the typical τ becomes so small that one
can consider propensities to be approximately constant.
The larger is the number of ion channels the better the
approximation works. The reason of this brief discussion
is to just inform the readers that the widely claimed ex-
act one is basically an approximate method, not exact
method. It diverges from the true action potential tra-
jectories as time propagates(as seen using Morris-Lecar
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model in reference [57]) for sufficiently small number of
channels. Although it is not at all bad for a patch size
of A= 200µm2. We have used the constant propensity
method. The results with this much of patch area is negli-
gibly affected and moreover our aim is to understand how
the physiological effects of drug blocking can be obtained
in general. Theoretical development on exact simulation
is not our focus here. For better understanding about
the discussion between the piece wise constant propen-
sity and time dependent propensity readers are advised
to read the following three references: [56–58].
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1Supplemental
Material
1. Effective ionic current: The effective ionic cur-
rent is given as, Iint = INa + IK + IL.
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FIG. S1: Effective ionic current is plotted here in
presence of sodium and potassium only blockers for
kon= 0.05 and 0.5 has been plotted with the case when
no drug is present. Here A= 200.0 µm2 and Iext= 6.9
µA/cm2. The left panel is for sodium only blockers and
the right panel is for potassium only blockers.
2. Dual Blockers, case: kson = kpon. The trend of
action potential termination for the case, kson = kpon is
shown below.
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FIG. S2: The action potential for the case kson = kpon
is plotted for affinity, kson = kpon= 0.001 to 0.5 with
A= 200.0 µm2 and Iext= 6.9 µA/cm
2.
3. Dual Blockers, case: kson > kpon The action po-
tential for the case kson > kpon shows very noisy action
potential trains. The peak height seems to fall gradually.
Thus the spikes which have peaks above -10 mV has been
considered in the paper works.
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FIG. S3: The trend of action potential termination the
case, kson > kpon is plotted here with A= 200.0 µm
2
and Iext= 6.9 µA/cm
2.
4. Dual Blockers, case: kpon > kson is similar to
that of potassium only blockers.
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FIG. S4: The action potential for the case kpon > kson
is plotted here for various affinities with A= 200.0 µm2
and Iext= 6.9 µA/cm
2.
